COPDのアウトカムに支支障管炎の変動性の影響
Joon Young Choi1, Yun Seok Kim1, Youlim Kim2
1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
BMJ open respiratory research
|September 3, 2025
まとめ
慢性閉塞性肺疾患 (COPD) の慢性閉塞性肺炎 (NB) 状態の患者と比較して,慢性閉塞性肺炎 (CB) と中断性肺炎 (IB) の患者は,悪化のリスクが高くなります. 肺機能の低下率は,これらのグループで有意な差異はなかった.
科学分野:
- 肺科
- 呼吸器医学
- 臨床流行病学
背景:
- 慢性閉塞性肺疾患 (COPD) は,世界的な健康問題です.
- ブロンキスの状態はCOPDの重要な現象であり,臨床結果に影響します.
- 連続気管支炎状態の縦断的な影響を理解することは,患者の管理に極めて重要です.
研究 の 目的:
- COPDの悪化頻度と肺機能の低下に対する2年間の持続的,断続的,および慢性肺炎の影響を評価する.
- 連続支氣管炎の状態に基づいて 異なる臨床経路を特定する.
主な方法:
- 韓国COPDサブグループ研究における1265人の参加者のデータを分析した.
- 2年以上のCOPD評価テストのサブクエステナリーに基づいて,患者の持続性非ブロンキティス (NB),間欠性ブロンキティス (IB),慢性ブロンキティス (CB) グループに分類する.
- 年間増悪率と長距離肺機能低下 (FEV1,FVC) の評価
主要な成果:
- この研究には873人のNB,272人のIB,そして120人のCB参加者が参加した.
- 慢性肺炎 (CB) と中断性肺炎 (IB) 群は,持続的に肺炎のない群と比較して,中等から重度の発症率が高かった.
- 3つのグループで年間肺機能低下率 (FEV1,FVC) の有意な差異は認められなかった.
- 現在の喫煙者はCBとIBグループでより多く見られた.
結論:
- 慢性気管支炎 (CB) と間歇性気管支炎 (IB) のフェノタイプを有する患者は,悪化のリスクが著しく高い.
- COPD患者における肺機能低下の速度には影響はない.
- これらの発見は,慢性および間歇性支氣管炎のフェノタイプを有する患者の悪化管理の重要性を強調しています.
関連する概念動画
01:26COPD: Management Using Bronchodilators and Corticosteroids
305
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
305
01:22Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
01:20COPD: Pathogenesis and Clinical Features
516
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
516
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K